Researching the Therapeutic Use of Psilocybin Globally

The ongoing debate surrounding the legalization and therapeutic use of psilocybin, the primary psychoactive compound found in various species of mushrooms, has gained significant attention in recent years. As research into the potential medical benefits of psilocybin continues to grow, so too does the need for a comprehensive understanding of its current legal status worldwide.

In an effort to provide clarity on this complex issue, this article aims to provide a holistic overview of the illicit substance of psilocybin globally, breaking down its restrictions by region and country.

In Canada, psilocybin was initially categorized as a Schedule III controlled substance under the Controlled Drugs and sporenspritze deutschland Substances Act.